UK healthcare professionals’ uncertainties, barriers and facilitators to the introduction of targeted human papillomavirus vaccination for men who have sex with men
Author(s) -
Tom Nadarzynski,
Carrie Llewellyn,
Daniel Richardson,
Alex Pollard,
Helen Smith
Publication year - 2017
Publication title -
sexual health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.117
H-Index - 43
eISSN - 1449-8987
pISSN - 1448-5028
DOI - 10.1071/sh17026
Subject(s) - vaccination , medicine , genital warts , men who have sex with men , family medicine , health care , human papillomavirus , hpv infection , hpv vaccines , health professionals , gynecology , cervical cancer , immunology , cancer , political science , human immunodeficiency virus (hiv) , syphilis , law
Female-only human papillomavirus (HPV) vaccination will fail to protect men who have sex with men (MSM) against HPV and its sequelae (i.e. genital warts and anal cancers). In the absence of gender-neutral HPV vaccination, targeted vaccination at sexual health clinics for MSM offers a valuable preventive opportunity. This study aimed to identify sexual healthcare professionals' (HCPs) perceived barriers and facilitators for MSM-targeted HPV vaccination.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom